| | World stocks rose on Wednesday as Wall Street and Europe bounced back from large drops, while oil prices continued to be weighed down by rising COVID-19 cases in Asia. | | | President Joe Biden on Wednesday announced tax credits for certain businesses that pay employees who take time off to get COVID-19 shots, a new effort to involve corporate America in his vaccination campaign. | | | A Canada judge has agreed to delay Huawei Chief Financial Officer Meng Wanzhou's U.S. extradition hearings for three months, according to a ruling read in court on Wednesday, handing her defense team a win. | | | A U.S. dollar rebound against major currencies was interrupted on Wednesday after Canada's central bank signaled it could start an interest rate hike in 2022 and reduced the scope of its asset-buying program. | | | Kinder Morgan's (KMI.N) profit more than doubled from the prior quarter and the U.S. pipeline operator raised its annual forecast as well as dividend, benefiting from a sudden demand surge for natural gas as fuel in Texas during the February winter storm. | | | Ryanair (RYA.I) expects a very strong profit recovery next year as it takes advantage of lower costs and a post-COVID retrenchment that may leave 25% less short-haul capacity in Europe, Group Chief Executive Michael O'Leary said on Wednesday. | | | Tesla Inc (TSLA.O) came under increased pressure in China on Wednesday from regulators and state media after Monday's protest by a disgruntled customer at the Shanghai auto show went viral and forced the electric car maker into a rare apology. | | | JPMorgan Chase & Co (JPM.N) is set to hire more junior bankers and support staff to tackle burnout as the largest U.S. bank takes on record volumes of activity, a source with knowledge of the matter said on Wednesday. | | | The European Union on Wednesday deflected concerns over its drive to formulate rules requiring companies to show investors how climate change will affect their activities, saying that waiting for a global approach could take years. | | | A U.S. plant that was making Johnson & Johnson's (JNJ.N) COVID-19 vaccine must fix a long list of problems including peeling paint and unsanitary conditions and practices to resume operation, according to a highly critical report by the Food and Drug Administration. | | | | |